{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:47:00Z","timestamp":1791103620810,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":2320,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5P01DK058327-08"],"award-info":[{"award-number":["5P01DK058327-08"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/mt.2010.64","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T14:08:24Z","timestamp":1271167704000},"page":"1076-1084","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Wai Han","family":"Yiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Mok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jiunn","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Y","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2010.64_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1566524024605798","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex","volume":"2","author":"Chou","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1038\/mt.2010.64_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM197602192940805","article-title":"Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease","volume":"294","author":"Greene","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2010.64_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM198401193100306","article-title":"Cornstarch therapy in type I glycogen-storage disease","volume":"310","author":"Chen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2010.64_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1067\/mpd.2001.111322","article-title":"Decreased urinary citrate excretion in type 1a glycogen storage disease","volume":"138","author":"Weinstein","year":"2001","journal-title":"J Pediatr"},{"issue":"Suppl 1","key":"10.1038\/mt.2010.64_bib5","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1038\/mt.2010.64_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/mt.2010.64_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jhep.2007.11.014","article-title":"Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia","volume":"48","author":"Kim","year":"2008","journal-title":"J Hepatol"},{"key":"10.1038\/mt.2010.64_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3302650","article-title":"Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer","volume":"13","author":"Ghosh","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.64_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","article-title":"Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia","volume":"13","author":"Koeberl","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.64_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/mt.2008.15","article-title":"AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia","volume":"16","author":"Koeberl","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.64_bib11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.64_bib12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/sj.gt.3302046","article-title":"Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver","volume":"10","author":"Loiler","year":"2003","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2010.64_bib13","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2010.64_bib14","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1128\/JVI.78.6.3110-3122.2004","article-title":"Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors","volume":"78","author":"Thomas","year":"2004","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.64_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1089\/104303401300042500","article-title":"CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice","volume":"12","author":"Xu","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2010.64_bib16","doi-asserted-by":"crossref","first-page":"14096","DOI":"10.1021\/bi9703249","article-title":"The role of HNF1alpha, HNF3gamma, and cyclic AMP in glucose-6-phosphatase gene activation","volume":"36","author":"Lin","year":"1997","journal-title":"Biochemistry"},{"key":"10.1038\/mt.2010.64_bib17","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1074\/jbc.272.18.11698","article-title":"A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin","volume":"272","author":"Streeper","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.64_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1043-2760(98)00123-4","article-title":"Molecular genetics of type 1 glycogen storage diseases","volume":"10","author":"Chou","year":"1999","journal-title":"Trend Endocrinol Metab"},{"key":"10.1038\/mt.2010.64_bib19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/mt.2008.72","article-title":"Gene delivery to the juvenile mouse liver using AAV2\/8 vectors","volume":"16","author":"Cunningham","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2010.64_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jgm.516","article-title":"Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle","volume":"6","author":"Brooks","year":"2004","journal-title":"J Gene Med"},{"key":"10.1038\/mt.2010.64_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.gene.2008.09.033","article-title":"Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice","volume":"428","author":"Mehta","year":"2009","journal-title":"Gene"},{"key":"10.1038\/mt.2010.64_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.1994.2719","article-title":"Effect of acute diabetes on rat hepatic glucose-6-phosphatase activity and its messenger RNA level","volume":"205","author":"Liu","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2010.64_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.nutr.19.1.511","article-title":"Metabolic engineering with recombinant adenoviruses","volume":"19","author":"Antinozzi","year":"1999","journal-title":"Annu Rev Nutr"},{"key":"10.1038\/mt.2010.64_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/diabetes.49.6.969","article-title":"Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes","volume":"49","author":"Clore","year":"2000","journal-title":"Diabetes"},{"key":"10.1038\/mt.2010.64_bib25","doi-asserted-by":"crossref","first-page":"32837","DOI":"10.1074\/jbc.M201853200","article-title":"The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis","volume":"277","author":"Ghosh","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2010.64_bib26","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","article-title":"Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo","volume":"75","author":"Nakai","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.64_bib27","doi-asserted-by":"crossref","first-page":"9093","DOI":"10.1128\/JVI.00895-06","article-title":"Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6","volume":"80","author":"Wu","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.64_bib28","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.00878-06","article-title":"The 37\/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9","volume":"80","author":"Akache","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mt.2010.64_bib29","first-page":"1","article-title":"Chemomorphology of liver parenchyma. Qualitative histochemical distribution patterns and quantitative sinusoidal profiles of G6Pase, G6PDH and malic enzyme activity and of glycogen content","volume":"14","author":"Teutsch","year":"1981","journal-title":"Prog Histochem Cytochem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616310462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T11:20:52Z","timestamp":1725794452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616310462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1525001616310462"],"URL":"https:\/\/doi.org\/10.1038\/mt.2010.64","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete Normalization of Hepatic G6PC Deficiency in Murine Glycogen Storage Disease Type Ia Using Gene Therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/mt.2010.64","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The American Society of Gene & Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}